Marionelle (Drospirenone, Ethinylestradiol | Lactose)

Marionelle, a combined oral contraceptive, is indicated for hormonal contraception and related menstrual management.

• Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential.
• Cycle regulation: helps achieve more predictable menstrual cycles and reduces irregular bleeding.
• Dysmenorrhea relief: can lessen menstrual pain associated with ovulatory cycles.

• Marionelle combines drospirenone, a progestogenic agent with anti‑mineralocorticoid and anti‑androgenic activity, and ethinylestradiol, a synthetic estrogen. The estrogen component suppresses the mid‑cycle surge of luteinizing hormone, while drospirenone inhibits follicular development and stabilizes the endometrium. Together they prevent ovulation, thicken cervical mucus, and alter the endometrial lining, creating conditions unfavorable for fertilization and implantation.

Marionelle may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Nausea: mild stomach upset, especially during the first cycles.
• Breast tenderness: temporary swelling or discomfort in the breasts.
• Headache: mild to moderate headaches.
• Spotting or breakthrough bleeding: irregular bleeding between periods.
• Weight gain: slight increase in body weight due to fluid retention.
• Mood changes: fluctuations in mood or emotional state.

Serious or Rare Side Effects

• Venous thromboembolism: blood clots in deep veins or lungs.
• Arterial thrombosis: clot formation in arteries leading to stroke or heart attack.
• Hypertension: significant increase in blood pressure.
• Liver disorders: jaundice or hepatic dysfunction.
• Gallbladder disease: inflammation or gallstones.
• Severe allergic reactions: rash, swelling, or anaphylaxis.

Before prescribing Marionelle, clinicians should evaluate several safety considerations.

• Assess cardiovascular risk: screen for history of thrombosis, hypertension, or smoking.
• Evaluate liver function: avoid use in patients with severe hepatic impairment.
• Review concomitant medications: consider potential interactions that may reduce efficacy.
• Counsel on smoking: advise women over 35 who smoke to use alternative methods.
• Avoid use in pregnancy: discontinue immediately if pregnancy is confirmed.
• Store at ambient temperature: keep tablets in original packaging, protect from moisture and direct sunlight.

Marionelle can interact with other medicines, affecting its effectiveness or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.
• Certain antiretrovirals (e.g., efavirenz, nevirapine): can lower hormone levels and increase risk of pregnancy.
• Other estrogen‑containing products (e.g., hormone replacement therapy): increase risk of thrombotic events.

Moderate Interactions (Monitor Closely)

• Anticoagulants (e.g., warfarin): oral contraceptives may alter INR values, requiring closer monitoring.
• St. John’s wort: may decrease hormone concentrations, potentially reducing contraceptive reliability.